AlboMitoMycin C

• CAT Number: M140655
• CAS Number: 111750-67-5
• Molecular Formula: C15H18N4O5
• Molecular Weight: 334.33
• Purity: ≥95%
• Storage: -20°C
• IUPAC Name: [(3S,4S,7R,8S,9R)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,6-diazapentacyclo[7.4.0.01,6.02,4.03,7]tridec-11-en-8-yl]methyl carbamate
• InChI: InChI=1S/C15H18N4O5/c1-5-9(16)10(20)8-6(4-24-13(17)22)15(23-2)11-7-3-18(15)14(8,12(5)21)19(7)11/h6-8,11H,3-4,16H2,1-2H3,(H2,17,22)/t6-,7+,8+,11+,14?,15-,19?/m1/s1
• InChIKey: ZOVLGAUVYBEUSN-ZWSGUIOPSA-N
• SMILES: CC1=C(C(=O)C2C(C3(C4C5N4C2(C1=O)N3C5)OC)COC(=O)N)N

AlboMitoMycin C（Cat No.:M140655） is a novel analog of Mitomycin C, a naturally occurring antibiotic and antitumor agent. AlboMitoMycin C has been chemically modified to improve its therapeutic properties, including increased stability and reduced side effects. It belongs to the family of aziridinomitosenes, which are known for their ability to cross-link DNA, thereby inhibiting cell division and inducing cell death. AlboMitoMycin C shows promise as a potent anticancer agent with a broad spectrum of activity against various types of cancer. It is currently being studied in preclinical and clinical trials for its potential in cancer therapy.